U.S. market Closed. Opens in 11 hours 52 minutes

CKPT | Checkpoint Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
Revenue103.00K192.00K268.00K1.07M1.71M3.51M1.73M2.57M590.00K
Cost of Revenue43.57M49.83M48.45M16.35M19.32MN/AN/AN/AN/A
Gross Profit-43.46M-49.63M-48.19M-15.28M-17.62M3.51MN/AN/AN/A
Operating Expenses52.25M58.52M56.99M24.27M26.56M40.25M24.50M24.73M13.81M
Selling, General & Admin8.69M8.70M8.54M7.92M7.23M6.59M5.42M4.47M2.49M
Research & Development43.57M49.83M48.45M16.35M19.32M33.65M19.08M20.27M11.32M
Other Operating ExpensesN/AN/AN/AN/AN/A225.00KN/AN/AN/A
Operating Income-52.15M-58.33M-56.72M-23.20M-24.85M-36.74M-22.77M-22.16M-13.22M
Other Expenses / Income301.00K-4.29M53.00K120.00K136.00K225.00K98.00K-297.00K-671.00K
Before Tax Income-51.85M-62.62M-56.67M-23.08M-24.71M-36.37M-22.68M-22.46M-13.89M
Income Tax Expenses-167.90K4.29M-53.00K-120.00K-136.00K-521.00KN/AN/AN/A
Net Income-51.85M-66.92M-56.62M-22.96M-24.58M-36.37M-22.68M-22.46M-13.89M
Interest ExpensesN/A4.29MN/AN/AN/AN/AN/A344.00K235.00K
Basic Shares Outstanding18.74M8.84M7.60M5.58M3.53M2.86M2.26M21.54M24.43M
Diluted Shares Outstanding18.74M8.84M7.60M5.58M3.53M2.86M2.26M21.54M24.43M
EBITDA-52.15M-53.88M-56.72M-23.20M-24.85M-36.74M-22.68M-22.12M-13.66M
EBITDA Margin-50,629.13%-28,063.54%-21,165.30%-2,170.35%-1,454.92%-1,047.92%-1,314.61%-860.58%-2,314.75%
EBIT-52.01M-58.33M-56.67M-23.08M-24.71M-36.89M-22.68M-22.12M-13.66M
EBIT Margin-50,499.90%-30,381.77%-21,145.52%-2,159.12%-1,446.96%-1,052.14%-1,314.61%-860.58%-2,314.75%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙